Scientists at the UCSF-affiliated Gladstone Institutes and the Stanford University School of Medicine have discovered how modifying a gene halts the toxic buildup of a protein found in nerve cells. These findings point to a potential new tactic for treating a variety of neurodegenerative conditions, including amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease).
October 29, 2012
August 29, 2012
Through the Immunological Immune Project, leading university immunologists and bioinformatics experts are probing genes to better understand how immune responses are coordinated. They aim to identify new ways to manipulate the immune system to better fight disease.